Perelman School of Medicine

Secondary cancers following CAR T cell therapy are rare

A new Penn Medicine analysis shows that the development of any type of second cancer is a rare occurrence, and some of the earliest patients have gone on to experience long-lasting remissions of a decade or more.

From Penn Medicine News

Q&A with Interim President J. Larry Jameson

Penn’s leader offers a glimpse into his background; his thoughts on academic freedom, shared governance, safety on campus; and his priorities for the semester ahead.

Penn Today Staff



In the News


Slate.com

What’s going on with tranq?

Jeanmarie Perron of the Perelman School of Medicine says that the appearance and progression of skin ulcers and tissue loss on xylazine users is different than with other intravenous drugs.

FULL STORY →



The Hill

It’s time to end the Medicare-Medicaid merry-go-round

In an opinion essay, Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that Medicare and Medicaid fail to integrate coverage and coordinate care across their two plans.

FULL STORY →



Philadelphia Inquirer

Inside Penn’s transfer center

Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.

FULL STORY →



Philadelphia Inquirer

Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use

Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.

FULL STORY →



Philadelphia Inquirer

Broad Street runners from Penn are racing with gyroscopes to study the Achilles tendon

Casey Jo Humbyrd and Josh Baxter of the Perelman School of Medicine and colleagues will track data from running the Broad Street Run to understand how a healthy Achilles tendon functions.

FULL STORY →